MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202611066219 A) filed by Jaypee Institute Of Information Technology on May 25, 2026, for A Pharmaceutical Composition Of Berberine And Olanzapine For The Management Of Breast Cancer.
Inventors include Shweta Dang; Pallavi Kumari; and Shalini Sharma.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention relates to a pharmaceutical composition comprising Berberine and Olanzapine for the treatment of breast cancer. More particularly, the present invention provides a synergistic combination of the natural bioactive compound Berberine and the repurposed pharmaceutical agent Olanzapine, w...